Insight

Liquid Biopsy Breakthrough – International Society of Liquid Biopsy

nature.com

Jan 15, 2025, 16:20

Liquid Biopsy Breakthrough – International Society of Liquid Biopsy

International Society of Liquid Biopsy (ISLB) shared a post on X about a recent paper by James Black et al. published in Nature Medicine:

“Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma”

Authors: James Black, Gabor Bartha, Charles Abbott, Richard Chen, Charles Swanton et al.

Liquid Biopsy Breakthrough - International Society of Liquid Biopsy

“Liquid Biopsy Breakthrough.

New ultrasensitive ctDNA detection tools like NeXT Personal achieve unparalleled sensitivity (1–3 ppm). This can revolutionize early-stage NSCLC management by:

Pre-op disease stratification
Predicting worse clinical outcomes
Identifying ultra-low-risk patients

Study Highlights:

81% detection in LUAD pre-op cases.
Significant OS impact: ctDNA presence = poorer survival.”

More posts International Society of Liquid Biopsy.

cancer Charles Abbott Charles Swanton ctDNA Gabor Bartha International Society of Liquid Biopsy ISLB James Black liquid biopsy lung adenocarcinoma OncoDaily Oncology Richard Chen

Oncodaily Launches New Social Channel on Telegram – @OncoDaily

In Memory of Chadwick Boseman and His Colon Cancer Battle

Groundbreaking Canadian Cancer Society-funded research aims to reshape the future of advanced cancer

CancerWorld is making a RETURN TO PRINT with its February 2025 issue

Oncologist Near Me - Douglas Flora: Pioneering AI Integration in Cancer Care